Medicines
Most widely sold generics first.
- Abraxane paclitaxel Advanced non-small cell lung cancer (NSCLC)
- Taxotere docetaxel Non-small cell lung cancer
- Iressa gefitinib EGFR-mutated non-small cell lung cancer that has spread
- Hycamtin topotecan Small cell lung cancer (SCLC)
- VePesid etoposide Small cell lung cancer
- Alecensa alectinib · No generic yet ALK-positive non-small cell lung cancer (NSCLC)
- Alunbrig brigatinib · No generic yet ALK-positive non-small cell lung cancer that has spread
- Augtyro repotrectinib · No generic yet Advanced ROS1-positive non-small cell lung cancer
- Avastin bevacizumab · No generic yet Non-squamous non-small cell lung cancer
- Bizengri zenocutuzumab · No generic yet Advanced lung cancer (NSCLC) with an NRG1 gene fusion
- Braftovi encorafenib · No generic yet Non-small cell lung cancer that has spread, with a BRAF mutation
- Datroway datopotamab deruxtecan · No generic yet Advanced EGFR-mutated non-small cell lung cancer
- Docivyx docetaxel · No generic yet Lung cancer (non-small cell)
- Doxorubicin No generic yet
- Emrelis telisotuzumab vedotin · No generic yet Non-small cell lung cancer with high c-Met protein
- Enhertu fam-trastuzumab deruxtecan-nxki · No generic yet Non-small cell lung cancer with a HER2 mutation
- Ensacove ensartinib · No generic yet ALK-positive non-small cell lung cancer
- Gavreto pralsetinib · No generic yet Lung cancer (NSCLC) with a RET fusion that has spread
- Gilotrif afatinib · No generic yet Lung cancer (NSCLC) that has spread, with certain EGFR mutations; Squamous lung cancer (NSCLC) that has spread
- Hernexeos zongertinib · No generic yet Advanced lung cancer (NSCLC) with a HER2 mutation
- Hyrnuo sevabertinib · No generic yet Advanced lung cancer (NSCLC) with a HER2 mutation
- Ibtrozi taletrectinib · No generic yet Advanced ROS1-positive lung cancer (NSCLC)
- Imdelltra tarlatamab-dlle · No generic yet Extensive-stage small cell lung cancer
- Imfinzi durvalumab · No generic yet Non-small cell lung cancer (NSCLC); Small cell lung cancer
- Imjudo tremelimumab · No generic yet Non-small cell lung cancer (NSCLC)
- Jideytro zidesamtinib · No generic yet ROS1-positive non-small cell lung cancer
- Keytruda pembrolizumab · No generic yet Lung cancer (NSCLC) and mesothelioma
- Keytruda Qlex pembrolizumab and berahyaluronidase alfa-pmph · No generic yet Lung cancer (NSCLC) and mesothelioma
- Krazati adagrasib · No generic yet Lung cancer (NSCLC) with a KRAS G12C mutation
- Lazcluze lazertinib · No generic yet Lung cancer (NSCLC) with certain EGFR mutations
- Libtayo cemiplimab-rwlc · No generic yet Non-small cell lung cancer (NSCLC)
- Lorbrena lorlatinib · No generic yet ALK-positive non-small cell lung cancer (NSCLC)
- Lumakras sotorasib · No generic yet KRAS G12C-mutated non-small cell lung cancer
- Mekinist trametinib · No generic yet Non-small cell lung cancer with a BRAF mutation
- Mektovi binimetinib · No generic yet Non-small cell lung cancer with a BRAF mutation
- Mvasi bevacizumab-awwb · No generic yet Non-squamous non-small cell lung cancer
- Opdivo nivolumab · No generic yet Non-small cell lung cancer
- Opdivo Qvantig nivolumab and hyaluronidase-nvhy · No generic yet Non-small cell lung cancer
- Pemrydi Rtu pemetrexed disodium · No generic yet Non-small cell lung cancer (non-squamous)
- Retevmo selpercatinib · No generic yet Non-small cell lung cancer with a RET gene fusion
- Rozlytrek entrectinib · No generic yet ROS1-positive non-small cell lung cancer
- Rybrevant amivantamab-vmjw · No generic yet Non-small cell lung cancer with an EGFR mutation
- Rybrevant Faspro amivantamab and hyaluronidase-lpuj (human recombinant) · No generic yet Non-small cell lung cancer with an EGFR mutation
- Tabrecta capmatinib · No generic yet Non-small cell lung cancer with a MET gene change
- Tafinlar dabrafenib · No generic yet Non-small cell lung cancer with a BRAF gene change
- Tagrisso osimertinib · No generic yet Non-small cell lung cancer with an EGFR gene change
- Tecentriq atezolizumab · No generic yet Non-small cell lung cancer (NSCLC); Small cell lung cancer
- Tecentriq Hybreza atezolizumab and hyaluronidase-tqjs · No generic yet Non-small cell lung cancer (NSCLC); Small cell lung cancer (SCLC)
- Tepmetko tepotinib · No generic yet Non-small cell lung cancer with a MET gene change
- Vegzelma bevacizumab-adcd · No generic yet Non-squamous non-small cell lung cancer
- Vizimpro dacomitinib · No generic yet Non-small cell lung cancer (NSCLC) with an EGFR mutation
- Xalkori crizotinib · No generic yet ALK- or ROS1-positive non-small cell lung cancer that has spread
- Yervoy ipilimumab · No generic yet Non-small cell lung cancer
- Zepzelca lurbinectedin · No generic yet Extensive-stage small cell lung cancer
- Zirabev bevacizumab-bvzr · No generic yet Non-squamous non-small cell lung cancer
- Zykadia ceritinib · No generic yet ALK-positive non-small cell lung cancer that has spread